Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
272111
Funder:
Canadian Institutes of Health Research
Funded outputs count:
10
Funder award ID:
272111
OpenAlex ID:
G2052260643
Development of 2-(5,6,7-Trifluoro-1H-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer
2021
·
Eric Leblanc
, Fuqiang Ban
, et al.
·
Journal of Medicinal Chemistry
·
13
Drugging the ‘undruggable’. Therapeutic targeting of protein–DNA interactions with the use of computer-aided drug discovery methods
2021
·
Mariia Radaeva
, Anh-Tien Ton
, et al.
·
Drug Discovery Today
·
44
PDF
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
2021
·
Fuqiang Ban
, Eric Leblanc
, et al.
·
Cancers
·
26
PDF
Development of Novel Inhibitors Targeting the D-Box of the DNA Binding Domain of Androgen Receptor
2021
·
Mariia Radaeva
, Fuqiang Ban
, et al.
·
International Journal of Molecular Sciences
·
31
PDF
Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer
2018
·
Kush Dalal
, Fuqiang Ban
, et al.
·
Cancer Letters
·
50
Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action
2017
·
Fuqiang Ban
, Kush Dalal
, et al.
·
Journal of Chemical Information and Modeling
·
109
Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation
2016
·
Nada Lallous
, Eric Leblanc
, et al.
·
Molecular Cancer Therapeutics
·
31
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
2016
·
Nada Lallous
, Stanislav V. Volik
, et al.
·
Genome biology
·
208
PDF
Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers
2014
·
Mani Roshan-Moniri
, Michael Hsing
, et al.
·
Cancer Treatment Reviews
·
42
Discovery of Small-Molecule Inhibitors Selectively Targeting the DNA-Binding Domain of the Human Androgen Receptor
2014
·
Huifang Li
, Fuqiang Ban
, et al.
·
Journal of Medicinal Chemistry
·
120
Show more works
View as search
Year
Topic